Home The Word Brain	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	The Word Brain 2015 – Free PDF | Print | Web A short guide to fast language learning	Free Abstracts

HIV Infection

Free Subscription Articles published in Scand J Infect Dis Retrieve available abstracts of 47 articles: HTML format Text format

Single Articles

November 2014
1. REY D, Treger M, Sibilia J, Priester M, et al
   Bone mineral density changes after 2 years of ARV treatment, compared to naive HIV-1-infected patients not on HAART.
   Scand J Infect Dis. 2014.
   PubMed     Text format     Abstract available
   
   
   October 2014
2. WIDGREN K, Skar H, Berglund T, Kling AM, et al
   Delayed HIV diagnosis common in Sweden, 2003-2010.
   Scand J Infect Dis. 2014.
   PubMed     Text format     Abstract available
   
   
   September 2014
3. MAZZOCATO S, Orsetti E, Gesuita R, Piraccini F, et al
   Comparison of liver fibrosis progression in HIV/HCV co-infected and HCV mono-infected patients by transient elastometry.
   Scand J Infect Dis. 2014.
   PubMed     Text format     Abstract available
   
   
   
4. GANTNER P, Koeppel C, Partisani M, Batard ML, et al
   Efficacy and safety of switching to raltegravir plus atazanavir dual therapy in pretreated HIV-1-infected patients over 144 weeks: a cohort study.
   Scand J Infect Dis. 2014.
   PubMed     Text format     Abstract available
   
   
   August 2014
5. BOLTHER M, Dalgaard LS, Kristensen LH, Tarp BD, et al
   Testing for hepatitis B virus and HIV in patients with chronic hepatitis C: Screening performance and outcome.
   Scand J Infect Dis. 2014.
   PubMed     Text format     Abstract available
   
   
   July 2014
6. SOMMESE L, Sabia C, Paolillo R, Parente D, et al
   Screening tests for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus in blood donors: Evaluation of two chemiluminescent immunoassay systems.
   Scand J Infect Dis. 2014.
   PubMed     Text format     Abstract available
   
   
   
7. ALBERT J, Berglund T, Gisslen M, Groon P, et al
   Risk of HIV transmission from patients on antiretroviral therapy: A position statement from the Public Health Agency of Sweden and the Swedish Reference Group for Antiviral Therapy.
   Scand J Infect Dis. 2014.
   PubMed     Text format     Abstract available
   
   
   
8. BICKEL M, Lais C, Wieters I, Kroon FP, et al
   Durability of protective antibody titres is not enhanced by a two-dose schedule of an ASO3-adjuvanted pandemic H1N1 influenza vaccine in adult HIV-1-infected patients.
   Scand J Infect Dis. 2014.
   PubMed     Text format     Abstract available
   
   
   
9. STENKVIST J, Weiland O, Sonnerborg A, Blaxhult A, et al
   High HCV treatment uptake in the Swedish HIV/HCV co-infected cohort.
   Scand J Infect Dis. 2014.
   PubMed     Text format     Abstract available
   
   
   June 2014
10. ANDERSEN KL, Larsen CS, Petersen MS, Leutscher PD, et al
    Need for improvements in the surveillance and management of chronic viral hepatitis in HIV patients followed in a Danish outpatient clinic.
    Scand J Infect Dis. 2014.
    PubMed     Text format     Abstract available
    
    
    
11. MADSEN LW, Fabricius T, Hjerrild S, Hansen TM, et al
    Depressive symptoms are frequent among drug users, but not associated with hepatitis C infection.
    Scand J Infect Dis. 2014.
    PubMed     Text format     Abstract available
    
    
    
12. SALADO-RASMUSSEN K, Knudsen A, Krarup HB, Katzenstein TL, et al
    Undetectable hepatitis C virus RNA during syphilis infection in two HIV/HCV-co-infected patients.
    Scand J Infect Dis. 2014.
    PubMed     Text format     Abstract available
    
    
    April 2014
13. NAVER L, Albert J, Bottiger Y, Carlander C, et al
    Prophylaxis and treatment of HIV-1 infection in pregnancy: Swedish recommendations 2013.
    Scand J Infect Dis. 2014.
    PubMed     Text format     Abstract available
    
    
    
14. FRANCISCI D, Falcinelli E, Baroncelli S, Petito E, et al
    Potential anti-inflammatory effects of maraviroc in HIV-positive patients: A pilot study of inflammation, endothelial dysfunction, and coagulation markers.
    Scand J Infect Dis. 2014.
    PubMed     Text format     Abstract available
    
    
    February 2014
15. WANNHEDEN C, Norrby M, Berggren I, Westling K, et al
    Tuberculosis among HIV-infected patients in Stockholm, Sweden, 1987-2010: Treatment outcomes and adverse reactions.
    Scand J Infect Dis. 2014.
    PubMed     Text format     Abstract available
    
    
    January 2014
16. ROBLOT F, Le Moal G, Kauffmann-Lacroix C, Bastides F, et al
    Pneumocystis jirovecii pneumonia in HIV-negative patients: A prospective study with focus on immunosuppressive drugs and markers of immune impairment.
    Scand J Infect Dis. 2014.
    PubMed     Text format     Abstract available
    
    
    November 2013
17. ABERS MS
    Predicted cardiovascular risk in HIV-infected patients.
    Scand J Infect Dis. 2013.
    PubMed     Text format    
    
    
    
18. KIM SB , Kim HW, Kim HS, Ann HW, et al
    Pooled nucleic acid testing to identify antiretroviral treatment failure during HIV infection in Seoul, South Korea.
    Scand J Infect Dis. 2013.
    PubMed     Text format     Abstract available
    
    
    October 2013
19. FABBIANI M , Mondi A, Colafigli M, D'Ettorre G, et al
    Safety and efficacy of treatment switch to raltegravir plus tenofovir/emtricitabine or abacavir/lamivudine in patients with optimal virological control: 48-week results from a randomized pilot study (Raltegravir Switch for Toxicity or Adverse Events,
    Scand J Infect Dis. 2013.
    PubMed     Text format     Abstract available
    
    
    
20. KOENIG KF , Kalbermatter S, Menter T, Graber P, et al
    Recurrent bone fractures due to tenofovir-induced renal phosphate wasting.
    Scand J Infect Dis. 2013.
    PubMed     Text format     Abstract available
    
    
    August 2013
21. KIM SB , Kim YC, Kim MH, Song JE, et al
    A comparison of the predicted risk for cardiovascular disease between HIV-infected and uninfected persons in Korea.
    Scand J Infect Dis. 2013.
    PubMed     Text format     Abstract available
    
    
    July 2013
22. HOFFMANN C , Kohrs F, Sabranski M, Wolf E, et al
    HIV-associated lung cancer: Survival in an unselected cohort.
    Scand J Infect Dis. 2013.
    PubMed     Text format     Abstract available
    
    
    
23. SNOPKOVA S , Pohanka M, Polak P, Havlickova K, et al
    Acute toxoplasmosis-etiological factor for development of Hodgkin's lymphoma?
    Scand J Infect Dis. 2013.
    PubMed     Text format     Abstract available
    
    
    
24. YEN YF , Hu BS, Lin YS, Li LH, et al
    Latent tuberculosis among injection drug users in a methadone maintenance treatment program, Taipei, Taiwan: TSPOT.TB versus tuberculin skin test.
    Scand J Infect Dis. 2013;45:504-11.
    PubMed     Text format     Abstract available
    
    
    May 2013
25. MALINCARNE L , Pasticci MB, Angeli G, Baldelli F, et al
    Syphilis as a diagnosis of liver abnormalities in HIV.
    Scand J Infect Dis. 2013.
    PubMed     Text format     Abstract available
    
    
    April 2013
26. LLIBRE JM , Revollo B, Vanegas S, Lopez-Nunez JJ, et al
    Pneumocystis jirovecii pneumonia in HIV-1-infected patients in the late-HAART era in developed countries.
    Scand J Infect Dis. 2013.
    PubMed     Text format     Abstract available
    
    
    March 2013
27. GAREDEW L , Mihret A, Ameni G
    Molecular typing of mycobacteria isolated from extrapulmonary tuberculosis patients at Debre Birhan Referral Hospital, central Ethiopia.
    Scand J Infect Dis. 2013.
    PubMed     Text format     Abstract available
    
    
    
28. ZUCMAN D , De Truchis P, Peytavin G, Descamps D, et al
    Efficacy, safety, and pharmacokinetics of once-daily boosted darunavir in pretreated HIV-infected patients.
    Scand J Infect Dis. 2013.
    PubMed     Text format     Abstract available
    
    
    February 2013
29. LEUTSCHER PD , Stecher C, Storgaard M, Larsen CS, et al
    Discontinuation of efavirenz therapy in HIV patients due to neuropsychiatric adverse effects.
    Scand J Infect Dis. 2013.
    PubMed     Text format     Abstract available
    
    
    January 2013
30. KIM T , Hong HL, Lee YM, Sung H, et al
    Is caspofungin really an effective treatment for Pneumocystis jirovecii pneumonia in immunocompromised patients without human immunodeficiency virus infection? Experiences at a single center and a literature review.
    Scand J Infect Dis. 2013.
    PubMed     Text format     Abstract available
    
    
    
31. ANDERSSON LM , Vesterbacka J, Blaxhult A, Flamholc L, et al
    Lopinavir/ritonavir, atazanavir/ritonavir, and efavirenz in antiretroviral-naive HIV-1-infected individuals over 144 weeks: An open-label randomized controlled trial.
    Scand J Infect Dis. 2013.
    PubMed     Text format     Abstract available
    
    
    
32. LEGARTH R , Helleberg M, Kronborg G, Larsen CS, et al
    Anal carcinoma in HIV-infected patients in the period 1995-2009: A Danish nationwide cohort study.
    Scand J Infect Dis. 2013.
    PubMed     Text format     Abstract available
    
    
    November 2012
33. ZHANG JC , Zhang HJ, Li Y, Jing D, et al
    Changes in levels of T cell subpopulations to monitor the response to antiretroviral therapy among HIV-1-infected patients during two years of HIV-1 replication suppression.
    Scand J Infect Dis. 2012.
    PubMed     Text format     Abstract available
    
    
    
34. DAVIES BS , Roberts CH, Kaul S, Klein JL, et al
    Non-tuberculous slow-growing mycobacterial pulmonary infections in non-HIV-infected patients in south London.
    Scand J Infect Dis. 2012;44:815-9.
    PubMed     Text format     Abstract available
    
    
    October 2012
35. KOTILAINEN H , Valtonen V, Tukiainen P, Poussa T, et al
    Prognostic value of American Thoracic Society criteria for non-tuberculous mycobacterial disease: A retrospective analysis of 120 cases with four years of follow-up.
    Scand J Infect Dis. 2012.
    PubMed     Text format     Abstract available
    
    
    September 2012
36. KARNITE A , Brigis G, Uuskula A
    Years of potential life lost due to HIV infection and associated factors based on national HIV surveillance data in Latvia, 1991-2010.
    Scand J Infect Dis. 2012.
    PubMed     Text format     Abstract available
    
    
    
37. PEFURA YONE EW , Kengne AP, Moifo B, Kuaban C, et al
    Prevalence and determinants of extrapulmonary involvement in patients with pulmonary tuberculosis in a Sub-Saharan African country: A cross-sectional study.
    Scand J Infect Dis. 2012.
    PubMed     Text format     Abstract available
    
    
    
38. CALZA L , Trapani F, Salvadori C, Magistrelli E, et al
    Incidence of renal toxicity in HIV-infected, antiretroviral-naive patients starting tenofovir/emtricitabine associated with efavirenz, atazanavir/ritonavir, or lopinavir/ritonavir.
    Scand J Infect Dis. 2012.
    PubMed     Text format     Abstract available
    
    
    July 2012
39. JANOLS H , Abate E, Idh J, Senbeto M, et al
    Early treatment response evaluated by a clinical scoring system correlates with the prognosis of pulmonary tuberculosis patients in Ethiopia: A prospective follow-up study.
    Scand J Infect Dis. 2012.
    PubMed     Text format     Abstract available
    
    
    
40. ROSSOTTI R , Moioli MC, Chianura L, Errante I, et al
    Lamivudine or emtricitabine (XTC)/protease inhibitor dual therapy as a harm-reduction strategy in patients with tenofovir-related renal toxicity: A case-control study.
    Scand J Infect Dis. 2012.
    PubMed     Text format     Abstract available
    
    
    
41. HA TT , Anh NM, Bao NH, Tuan PL, et al
    HIV-1 mother-to-child transmission, post-test counselling, and antiretroviral prophylaxis in Northern Viet Nam: A prospective observational study.
    Scand J Infect Dis. 2012.
    PubMed     Text format     Abstract available
    
    
    
42. LOULERGUE P , Mir O
    Raltegravir-induced DRESS syndrome.
    Scand J Infect Dis. 2012.
    PubMed     Text format     Abstract available
    
    
    
43. THORSTEINSSON K , Ladelund S, Jensen-Fangel S, Larsen MV, et al
    Impact of gender on the risk of AIDS-defining illnesses and mortality in Danish HIV-1-infected patients: A nationwide cohort study.
    Scand J Infect Dis. 2012.
    PubMed     Text format     Abstract available
    
    
    
44. GISSLEN M , Fuchs D, Hagberg L, Svennerholm B, et al
    Cerebrospinal fluid viral breakthrough in two HIV-infected subjects on darunavir/ritonavir monotherapy.
    Scand J Infect Dis. 2012.
    PubMed     Text format     Abstract available
    
    
    June 2012
45. ZHANG JC , Sun YT
    Efavirenz-induced exfoliative dermatitis.
    Scand J Infect Dis. 2012.
    PubMed     Text format     Abstract available
    
    
    
46. RASCH MG , Engsig FN, Feldt-Rasmussen B, Kirk O, et al
    Renal function and incidence of chronic kidney disease in HIV patients: A Danish cohort study.
    Scand J Infect Dis. 2012.
    PubMed     Text format     Abstract available
    
    
    May 2012
47. MALEKMOHAMMAD M , Marjani M, Tabarsi P, Baghaei P, et al
    Diagnostic yield of post-bronchoscopy sputum smear in pulmonary tuberculosis.
    Scand J Infect Dis. 2012;44:369-73.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: